212
Views
16
CrossRef citations to date
0
Altmetric
Review

Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension

&
Pages 741-764 | Published online: 09 Jul 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Henrietta Wang, Katherine Masselos, Michael Kalloniatis & Jack Phu. (2021) Headaches related to latanoprost in open-angle glaucoma. Clinical and Experimental Optometry 104:5, pages 625-633.
Read now
Francisco José Muñoz Negrete, Hans G Lemij & Carl Erb. (2017) Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction. Clinical Ophthalmology 11, pages 557-566.
Read now
Nurettin Akyol, Ahmet Kalkisim, Adem Turk, Mehmet Kola & Halil Ibrahim Imamoglu. (2017) Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination. Cutaneous and Ocular Toxicology 36:4, pages 397-403.
Read now
Giancarlo A Garcia, Philip Ngai, Sameh Mosaed & Ken Y Lin. (2016) Critical evaluation of latanoprostene bunod in the treatment of glaucoma. Clinical Ophthalmology 10, pages 2035-2050.
Read now
Jed Asher Lusthaus & Ivan Goldberg. (2016) Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors. Expert Opinion on Emerging Drugs 21:1, pages 117-128.
Read now
Shunsuke Nakakura, Minamai Yamamoto, Etsuko Terao, Nozomi Nagatomi, Naoko Matsuo, Yausko Fujisawa, Yuki Fujio, Hitoshi Tabuchi & Yoshiaki Kiuchi. (2015) Prostaglandin-associated periorbitopathy in latanoprost users. Clinical Ophthalmology 9, pages 51-56.
Read now
Priscilla Xinhui Wang, Victor Teck Chang Koh & Jin Fong Cheng. (2014) Periorbital muscle atrophy associated with topical bimatoprost therapy. Clinical Ophthalmology 8, pages 311-314.
Read now
Leopoldo Martín Baiza-Durán, Juan Francisco Llamas-Moreno & Clotilde Ayala-Barajas. (2012) Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 6, pages 1051-1055.
Read now

Articles from other publishers (7)

Wissam Georges El Hajj Moussa, Rebecca Georges Farhat, Joseph Claud Nehme, Marwan Antoun Sahyoun, Alexandre Raymond Schakal, Alexandre Edmond Jalkh, Mariana Pierre Abi Karam & Georges Georges Azar. (2018) Comparison of Efficacy and Ocular Surface Disease Index Score between Bimatoprost, Latanoprost, Travoprost, and Tafluprost in Glaucoma Patients. Journal of Ophthalmology 2018, pages 1-7.
Crossref
Thomas Mathew, Naveen Kumar, Nitin Batra & Rupali Chopra. (2017) A STUDY OF THE EFFECTS OF TOPICAL TIMOLOL 0.5% AND BIMATOPROST 0.03% ON THE OCULAR SURFACE. Journal of Evidence Based Medicine and Healthcare 4:46, pages 2796-2799.
Crossref
Yury S Astakhov & Pavel A Nechiporenko. (2017) Prostaglandin analogues: past, present, and future. Ophthalmology Reports 10:1, pages 40-52.
Crossref
Prempal Kaur, Vishal Brar, Bhavkaran Singh Bal & Inderjit Kaur. (2016) A COMPARATIVE STUDY TO ASSESS THE EFFICACY AND TOLERABILITY OF LATANOPROST, BIMATOPROST AND TRAVOPROST IN PATIENTS WITH OPEN ANGLE GLAUCOMA. Journal of Evidence Based Medicine and Healthcare 3:44, pages 2169-2175.
Crossref
Sergey Yuryevich Astakhov, Yuriy Sergeyevich Astakhov & Medeya Vakhtangovna Gobedzhishvili. (2014) The influence of prostaglandin analogs on the retinal thickness after phacoemulsification with intraocular lens implantation in primary open-angle glaucoma patients. Ophthalmology Reports 7:3, pages 73-76.
Crossref
Jose Francisco Ortega-Santana. (2013) Tolerancia y Efectividad de los Análogos de Prostaglandinas en Pacientes Glaucomatosos. Highlights of Ophthalmology 41:3ESP, pages 22-26.
Crossref
Jose Francisco Ortega-Santana. (2013) Tolerance and Effectivity of Prostaglandin Analogues in Glaucoma Patients. Highlights of Ophthalmology 41:3ENG, pages 19-22.
Crossref